keyword
MENU ▼
Read by QxMD icon Read
search

Prostate specific antigen, bph

keyword
https://www.readbyqxmd.com/read/28073286/bipolar-plasmakinetic-enucleo-resection-of-the-prostate-our-exp%C3%A3-rience-with-245-patients-for-3-years-of-follow-up
#1
Ahmed Abou-Taleb, Waleed El-Shaer, Wael Saber, Tarek Gharib, Alaa Elshaer
OBJECTIVE: the aim of this study was to evaluate the safety, feasibility and effectiveness of bipolar transurethral plasmakinetic enucleation of the prostate (PKEP). PATIENTS AND METHOD: Between January 2010 and October 2013, 245 patients with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) underwent transurethral enucleation of prostate using bipolar plasma vaporization energy. They were evaluated pre-operatively by Full detailed history, examination especially digital rectal examination (DRE), routine pre-operative investigation, serum prostate-specific antigen (PSA), abdominal and trans-rectal ultrasonography (US) and Maximum flow rates (Qmax)...
January 10, 2017: Journal of Endourology
https://www.readbyqxmd.com/read/28043110/obesity-as-a-risk-factor-for-prostatic-enlargement-a-retrospective-cohort-study-in-korea
#2
Jae Hung Jung, Song Vogue Ahn, Jae Mann Song, Se-Jin Chang, Kwang Jin Kim, Sung Won Kwon, Sang-Yoo Park, Sang-Baek Koh
PURPOSE: We aimed to evaluate obesity, a risk factor of metabolic syndrome, and its association with prostatic enlargement in a retrospective cohort in Korea. METHODS: Baseline data were obtained from the Korean Genome and Epidemiology Study on Atherosclerosis Risk of Rural Areas in the Korean General Population (KoGES-ARIRANG). Between March 2015 and November 2015, 2,127 male participants of KoGES-ARIRANG were invited to the Korean Prostate Health Council Screening Program, and 602 participants underwent urological examination, including serum prostate specific antigen measurement and transrectal ultrasonography, and completed the International Prostate Symptom Score questionnaire...
December 2016: International Neurourology Journal
https://www.readbyqxmd.com/read/28043105/association-study-of-polymorphisms-of-epidermal-growth-factor-and-epidermal-growth-factor-receptor-with-benign-prostatic-hyperplasia-in-a-korean-population
#3
Su Kang Kim, Hyun Kyung Park, Han Sung Choi, Koo Han Yoo, Joo-Ho Chung
PURPOSE: Recent studies have suggested that specific single-nucleotide polymorphisms (SNPs) contribute to the clinical features of benign prostatic hyperplasia (BPH). In this study, we investigated the relationships of genetic polymorphisms of the epidermal growth factor (EGF) gene and the epidermal growth factor receptor (EGFR) gene with BPH. METHODS: A total of 218 patients with BPH were enrolled in this study. We evaluated the relationship between eight SNPs in the EGF and EGFR genes and prostate volume, prostate-specific antigen (PSA), and International Prostate Symptom Score of BPH patients...
December 2016: International Neurourology Journal
https://www.readbyqxmd.com/read/28043104/long-term-combination-therapy-with-%C3%AE-blockers-and-5%C3%AE-reductase-inhibitors-in-benign-prostatic-hyperplasia-patient-adherence-and-causes-of-withdrawal-from-medication
#4
Hueih Ling Ong, Chun-Hou Liao, Hann-Chorng Kuo
PURPOSE: To investigate long-term therapeutic effects and patient adherence to a combination therapy of a 5α-reductase inhibitor and an α-blocker and to identify causes of withdrawal from medication in patients with clinical benign prostatic hyperplasia (BPH). METHODS: BPH patients with lower urinary tract symptoms (LUTS) receiving combination therapy with follow-ups for 1-12 years were retrospectively analyzed. Therapeutic effects were assessed at baseline and annually by measuring International Prostatic Symptoms Score, quality of life index, total prostate volume (TPV), maximal flow rate, voided volume, postvoid residual volume and prostate-specific antigen level...
December 2016: International Neurourology Journal
https://www.readbyqxmd.com/read/28042794/effect-of-onabotulinum-toxin-type-a-intraprostatic-injection-on-the-outcome-of-benign-prostatic-hyperplasia-patients-refractory-to-medical-therapy-a-2-year-follow-up-study
#5
Tiago Gorgal Rodrigues de Carvalho, Rui Pinto, Francisco Cruz, João Silva
OBJECTIVES: To determine the outcome of Benign Prostatic Hyperplasia patients refractory to standard medical therapy and with significant comorbidities submitted to intraprostatic injection of onabotulinum toxin A. METHODS: Thirty-seven patients with symptomatic Benign Prostatic Hyperplasia refractory to medical therapy who were poor candidates for surgical treatment were enrolled. All patients voided spontaneously. They received one single transrectal application of 200 U of onabotulinum toxin A...
December 2016: Archivos Españoles de Urología
https://www.readbyqxmd.com/read/28008272/different-levels-of-serum-micrornas-in-prostate-cancer-and-benign-prostatic-hyperplasia-evaluation-of-potential-diagnostic-and-prognostic-role
#6
Giovanni Cochetti, Giulia Poli, Gabriella Guelfi, Andrea Boni, Maria Giulia Egidi, Ettore Mearini
INTRODUCTION: Diagnosis of prostate cancer (PCa) is based on prostate biopsy that is performed when prostate specific antigen (PSA) is persistently altered over time and/or abnormal digital rectal examination is found. Serum PSA levels increase in both PCa and benign prostatic hyperplasia, leading to an increased number of unnecessary biopsies. There is an urgent need to unravel PCa-specific molecular signatures. PATIENTS AND METHODS: This study aimed at characterizing a panel of circulating micro RNAs (miRNAs) that could distinguish PCa from benign prostatic hyperplasia in a population of age-matched patients with increased PSA levels...
2016: OncoTargets and Therapy
https://www.readbyqxmd.com/read/27998216/biases-in-recommendations-for-and-acceptance-of-prostate-biopsy-significantly-affect-assessment-of-prostate-cancer-risk-factors-results-from-two-large-randomized-clinical-trials
#7
Catherine M Tangen, Phyllis J Goodman, Cathee Till, Jeannette M Schenk, M Scott Lucia, Ian M Thompson
Purpose To identify factors related to who undergoes a prostate biopsy in a screened population and to estimate the impact of biopsy verification on risk factor-prostate cancer associations. Patients and Methods Men who were screened regularly from the placebo arms of two large prostate cancer prevention trials (Prostate Cancer Prevention Trial [PCPT] and Selenium and Vitamin E Cancer Prevention Trial [SELECT]) were examined to define incident prostate cancer cohorts. Because PCPT had an end-of-study biopsy, prostate cancer cases were categorized by a preceding prostate-specific antigen/digital rectal examination prompt (yes/no) and noncases by biopsy-proven negative status (yes v no)...
December 20, 2016: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/27956935/an-analytical-study-of-prostate-specific-antigen-dynamics
#8
Ernesto P Esteban, Giovanni Deliz, Jaileen Rivera-Rodriguez, Stephanie M Laureano
The purpose of this research is to carry out a quantitative study of prostate-specific antigen dynamics for patients with prostatic diseases, such as benign prostatic hyperplasia (BPH) and localized prostate cancer (LPC). The proposed PSA mathematical model was implemented using clinical data of 218 Japanese patients with histological proven BPH and 147 Japanese patients with LPC (stages T2a and T2b). For prostatic diseases (BPH and LPC) a nonlinear equation was obtained and solved in a close form to predict PSA progression with patients' age...
2016: Computational and Mathematical Methods in Medicine
https://www.readbyqxmd.com/read/27956827/efficacy-and-safety-of-prostate-artery-embolization-on-lower-urinary-tract-symptoms-related-to-benign-prostatic-hyperplasia-a-systematic-review-and-meta-analysis
#9
Xiao-Yan Wang, Huan-Tao Zong, Yong Zhang
BACKGROUND: Prostate artery embolization (PAE) is emerging and is a promising minimally invasive therapy that improves lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH). The purpose of this article was to evaluate the efficacy and safety of PAE on LUTS related to BPH. MATERIALS AND METHODS: A literature review was performed to identify all published articles of PAE for BPH. The sources included MEDLINE, EMBASE and Cochrane Library from 1980 to 2016...
2016: Clinical Interventions in Aging
https://www.readbyqxmd.com/read/27941343/detection-of-prostate-cancer-metastasis-by-whole-body-magnetic-resonance-imaging-combined-with-bone-scintigraphy-and-psa-levels
#10
Hengqing An, Ning Tao, Jia Li, Yonghui Guan, Wenguang Wang, Yujie Wang, Feng Wang
BACKGROUND/AIMS: The combined role of whole-body magnetic resonance imaging (WB-MRI), bone scintigraphy and prostate specific antigen (PSA) were considered in predicting metastases and prognosis of prostate cancer (PCa). METHODS: Totally 38 PCa patients underwent WB-MRI, bone scintigraphy and PSA detections, and 34 benign prostate hyperplasia (BPH) patients were checked with PSA. Pearson correlations were performed to determine associations among PSA, apparent diffusion coefficient (ADC) and Gleason scoring...
2016: Cellular Physiology and Biochemistry
https://www.readbyqxmd.com/read/27932164/retzius-space-preservation-technique-for-robotic-assisted-laparoscopic-radical-prostatectomy-in-a-kidney-transplant-patient-first-case-in-thailand-and-our-first-experience
#11
P Jenjitranant, P Sangkum, P Sirisreetreerux, W Viseshsindh, S Patcharatrakul, W Kongcharoensombat
OBJECTIVE: The aim of this work was to report our experience in robotic-assisted laparoscopic radical prostatectomy for the treatment of localized prostate cancer in a kidney transplant recipient. METHODS: A 73-year-old man with chronic renal failure underwent living-donor kidney transplantation (KT) in 1993. His baseline creatinine after KT was ∼1.2 mg/dL. He developed lower urinary tract symptoms in 1999. He was diagnosed with benign prostatic hyperplasia and treated accordingly...
November 2016: Transplantation Proceedings
https://www.readbyqxmd.com/read/27928815/comparing-monotherapy-with-tadalafil-or-tamsulosin-and-their-combination-therapy-in-men-with-benign-prostatic-hyperplasia-a-randomized-clinical-trial
#12
Hossein Karami, Amin Hassanzadeh-Hadad, Morteza Fallah-Karkan
PURPOSE: To compare monotherapy with tadalafil or tamsulosin and their combination therapy in men with benignprostatic hyperplasia and erectile dysfunction by comparing IPSS score, prostate volume and Qmax and someother outcomes. MATERIALS AND METHODS: This randomized, single-blind, paralleled group clinical trial was done in 2013 on patientswho had referred to our hospital in Tehran. All patients with lower urinary tract symptoms, benign prostatichyperplasia and any grade of erectile dysfunction were recruited...
8, 2016: Urology Journal
https://www.readbyqxmd.com/read/27928444/the-remote-effects-of-intravitreal-anti-vegf-therapy
#13
Balta F, Merticariu M, Taban C, Neculau G, Merticariu A, Muresanu D, Badescu D, Jinga V
Objective: To study the effects of intravitreal anti-Vascular Endothelial Growth Factor (VEGF) therapy with Avastin for wet Age-Related Macular Degeneration (AMD) on Benign Prostatic Hyperplasia (BPH)-related symptoms. Methods: An exploratory trial was conducted from August 1, 2013 to February 1, 2014, that included 14 male patients previously diagnosed with BPH, who were aged between 59 and 69 years. The trial was performed in Bucharest and involved two medical institutions: the Clinical Hospital of Eye Emergencies and the "Prof...
October 2016: Journal of Medicine and Life
https://www.readbyqxmd.com/read/27924709/occupational-risk-factors-for-prostate-cancer-in-an-area-of-former-coal-iron-and-steel-industries-in-germany-part-2-results-from-a-study-performed-in-the-1990s
#14
Sabina Krech, Silvia Selinski, Hannah Bürger, Jan G Hengstler, Peter Jedrusik, Jasmin Hodzic, H-Jürgen Knopf, Klaus Golka
Currently, there is no established occupational risk factor for prostate cancer. However, in the 1980s, a hospital-based case-control study in the greater Dortmund area showed an elevated risk for hard coal miners and, based on few cases, for painters and varnishers. Therefore, approximately 10 yr later, a similar study regarding prostate cancer was performed in this area. In total, 292 patients with prostate cancer who underwent radical prostatectomy and 313 controls who underwent transurethral resection of a benign prostatic hyperplasia were investigated by questionnaire...
2016: Journal of Toxicology and Environmental Health. Part A
https://www.readbyqxmd.com/read/27896579/prostatic-artery-embolization-in-treating-benign-prostatic-hyperplasia-a-systematic-review
#15
Jeremy Y C Teoh, Peter K F Chiu, Chi-Hang Yee, Hon-Ming Wong, Chi-Kwok Chan, Eddie S Y Chan, Simon S M Hou, Chi-Fai Ng
INTRODUCTION: We systemically reviewed the current evidence on prostatic artery embolization (PAE) in treating men with benign prostatic hyperplasia. METHODS: A systemic literature search was conducted in PubMed, EMBASE and Web of Science on 1 May 2016 without time constraints. Outcomes of interest included the changes in the International Prostate Symptom Score (IPSS), quality-of-life (QOL) score, peak urinary flow (Qmax), post-void residual urine (PVR), International Index of Erectile Function (IIEF) score, prostate volume (PV) and prostate-specific antigen (PSA) level...
November 28, 2016: International Urology and Nephrology
https://www.readbyqxmd.com/read/27880726/chrysophanic-acid-reduces-testosterone-induced-benign-prostatic-hyperplasia-in-rats-by-suppressing-5%C3%AE-reductase-and-extracellular-signal-regulated-kinase
#16
Dong-Hyun Youn, Jinbong Park, Hye-Lin Kim, Yunu Jung, JongWook Kang, Mi-Young Jeong, Gautam Sethi, Kwang Seok Ahn, Jae-Young Um
Benign prostatic hyperplasia (BPH) is one of the most common chronic diseases in male population, of which incidence increases gradually with age. In this study, we investigated the effect of chrysophanic acid (CA) on BPH. BPH was induced by a 4-week injection of testosterone propionate (TP). Four weeks of further injection with vehicle, TP, TP + CA, TP + finasteride was carried on. In the CA treatment group, the prostate weight was reduced and the TP-induced histological changes were restored as the normal control group...
November 17, 2016: Oncotarget
https://www.readbyqxmd.com/read/27863699/systematic-review-and-meta-analysis-of-prostatic-artery-embolisation-for-lower-urinary-tract-symptoms-related-to-benign-prostatic-hyperplasia
#17
J-S Pyo, W J Cho
AIM: To evaluate the efficacy of prostatic artery embolisation (PAE) in lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH) at short- and mid-term follow-up. MATERIALS AND METHODS: The current study included 484 BPH patients from seven eligible studies. A meta-analysis was performed to determine the mean differences in parameters associated with LUTS, including the international prostate symptom score (IPSS), peak urinary flow (Qmax), post-void residual volume (PVR), quality of life score (QoL), prostate-specific antigen level (PSA), and prostatic volume (PV), between baseline and follow-up periods...
January 2017: Clinical Radiology
https://www.readbyqxmd.com/read/27842896/kinesin-family-member-11-mrna-expression-predicts-prostate-cancer-aggressiveness
#18
Xuan-Mei Piao, Young Joon Byun, Pildu Jeong, Yun-Sok Ha, Eun Sang Yoo, Seok Joong Yun, Wun-Jae Kim
BACKGROUND: KIF11 (kinesin family member 11), a molecular motor protein, is essential to mitosis and cell cycle progression. Inhibitors of KIF11 have been developed as chemotherapeutic agents for the treatment of various cancers. Regarding prostate cancer (PCa), clinical trials using KIF11 inhibitors for the treatment of castration-resistant PCa have been initiated. We hypothesized that a relationship might exist between KIF11 expression and PCa. To investigate the functional activities and clinical usefulness of KIF11 in PCa, we used quantitative real-time reverse transcriptase polymerase chain reaction to monitor the KIF11 expression patterns...
October 19, 2016: Clinical Genitourinary Cancer
https://www.readbyqxmd.com/read/27826135/pim-3-is-a-critical-risk-factor-in-development-and-prognosis-of-prostate-cancer
#19
Yanchun Qu, Changwen Zhang, E Du, Andi Wang, Yuming Yang, Jianing Guo, Aixiang Wang, Zhihong Zhang, Yong Xu
BACKGROUND Pim-3 kinase is a highly homologous serine/threonine kinase that is overexpressed in hematological malignancies and solid tumors. Few studies have been conducted to define the role of Pim-3 in solid tumors, especially in prostate cancer. The aim of this study was to define the role of Pim-3 in development and prognosis of prostate cancer. MATERIAL AND METHODS We collected specimens from 160 patients with prostate cancer, as well as 100 patients with benign prostatic hyperplasia. Realtime polymerase chain reaction was used for the assessment of Pim-3 expression at the RNA level and Western blot was used to quantify the Pim-3 protein synthesis in 3 different cell lines...
November 9, 2016: Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
https://www.readbyqxmd.com/read/27813361/high-serum-dihydrotestosterone-examined-by-ultrasensitive-lc-ms-ms-as-a-predictor-of-benign-prostatic-hyperplasia-or-gleason-score-6-cancer-in-men-with-prostate-specific-antigen-levels-of-3-10%C3%A2-ng-ml
#20
Y Miyoshi, H Uemura, K Suzuki, Y Shibata, S Honma, M Harada, Y Kubota
There has been no consensus on the role of serum androgen concentrations in prostate cancer detection in men with prostate-specific antigen levels of 3-10 ng/mL. In this study, testosterone and dihydrotestosterone concentrations in blood were examined by a newly developed method using ultrasensitive liquid chromatography with two serially linked mass spectrometers (LC-MS/MS). We investigated the correlation between serum androgen levels and Gleason scores at biopsy. We analyzed data of 157 men with a total prostate-specific antigen range of 3-10 ng/mL who underwent initial systematic prostate needle biopsy for suspected prostate cancer between April 2000 and July 2003...
November 3, 2016: Andrology
keyword
keyword
25555
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"